Gyre Therapeutics Inc. Revenue 2009–2025
Gyre Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Gyre Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 22.5 M, a 2.09% increase year-over-year.
- Gyre Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 101.9 M, a 7.29% decrease year-over-year.
- Gyre Therapeutics Inc. annual revenue for 2025 was 116.6 M, a 10.24% increase from 2024.
- Gyre Therapeutics Inc. annual revenue for 2024 was 105.8 M, a 6.78% decrease from 2023.
- Gyre Therapeutics Inc. annual revenue for 2023 was 113.5 M, a 10.91% increase from 2022.
- Gyre Therapeutics Inc. annual revenue for 2022 was 102.3 M.
Gyre Therapeutics Inc. (GYRE) — Frequently Asked Questions
Gyre Therapeutics Inc. (GYRE) is a publicly traded US company. It has a market capitalization of $614M. In fiscal 2025 it reported revenue of $117M and net income of $10M. Explore GYRE's stock price, financial statements, earnings history, margins and key ratios below.
What is Gyre Therapeutics Inc.'s market cap?
Gyre Therapeutics Inc. (GYRE) has a market capitalization of $614M.
What is the GYRE stock price?
GYRE trades at $5.95 (-2.94% on the day).
How much revenue does Gyre Therapeutics Inc. make?
Gyre Therapeutics Inc. reported revenue of $117M in fiscal 2025.
Is GYRE profitable?
In fiscal 2025, Gyre Therapeutics Inc. reported net income of $10M.
What is GYRE's P/E ratio?
Based on diluted EPS, GYRE has a price-to-earnings (P/E) ratio of about 297.5.